Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens [NA]
ARTIDIS AG is evaluating nanomechanical signature profiling on pancreatic cancer specimens in a clinical trial. The study is currently recru…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors [Phase 1]
Phase I study update for the radiopharmaceutical [177Lu]Lu-DFC413 in patients with various solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma [NA]
This clinical trial update describes PDAC-PATHWAYS, a digital informational and supportive care app for patients initiating neoadjuvant ther…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating SGN-CEACAM5C in adults with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC [Phase 2]
Phase 2 clinical trial evaluating AGEN1423 and Botensilimab with or without chemotherapy in advanced pancreatic ductal adenocarcinoma; curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
A Phase 3 clinical trial evaluating 18F-FAPI PET imaging to detect metastatic disease in pancreatic ductal adenocarcinoma, currently recruit…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. [Phase 1]
Pfizer is conducting a Phase 1 study of PF-07934040 in adults with advanced solid tumors carrying a genetic mutation, evaluating the drug al…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors [Phase 1]
Phase 1 trial MOONRAY-01 evaluating LY3962673 in KRAS G12D-mutant solid tumors is currently recruiting. The study appears to include pancrea…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: OSCAR II STUDY - The ONCObind CTC Removal Study [NA]
Update on the OSCAR II Study evaluating the ONCObind circulating tumor cell (CTC) removal device; the trial status is not yet recruiting for…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB) [NA]
This clinical trial aims to develop functional, personalized profiling of biopsied pancreatic tumors (pancreatic ductal adenocarcinoma) usin…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content. [NA]
A clinical trial is evaluating an app that allows pancreatic cancer patients to monitor progress via targeted questionnaires and educational…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation [Phase 1]
This clinical trial update describes a Phase 1 dose-escalation study of the investigational KRAS inhibitor KST-6051 in adults with KRAS-muta…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer
This ClinicalTrials.gov entry describes a prospective study hosted by Chang Gung Memorial Hospital that will profile metabolomic and immune-…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI) [Phase 2]
INDIGO-FAPI is a Phase 2 clinical trial investigating PET-FAPI imaging for earlier detection of pancreatic ductal adenocarcinoma, currently …
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma [NA]
A clinical trial investigating surgical resection for synchronous pulmonary or hepatic oligometastatic pancreatic ductal adenocarcinoma has …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors [Phase 1]
This ClinicalTrials.gov entry describes a Phase 1 study to determine a suitable dose of ASP5834 in adults with solid tumors, including non-s…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study [Phase 2]
A Phase 2 clinical trial update for the PIONEER-Panc study evaluating new and emerging therapies for pancreatic cancer at various stages (re…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors [Phase 1]
An ongoing Phase 1 trial is evaluating BL-M05D1 in patients with solid tumors, assessing safety, tolerability, pharmacokinetics, and prelimi…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors [Phase 1]
KO-2806 is being studied in Phase 1 trials as a monotherapy and in combination regimens for advanced solid tumors, including HRAS-altered ca…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma [NA]
A recruiting clinical trial from The University of Texas Health Science Center at San Antonio is evaluating surgical resection for pancreati…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial is evaluating adding CA-4948 to standard chemotherapy for metastatic or unresectable pancreatic cancer and the stud…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
A clinical trial update describes a study evaluating microRNA as a diagnostic, prognostic, and treatment-response biomarker in pancreatic ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer [Phase 1]
Phase 1 clinical trial evaluating gemcitabine plus leflunomide for advanced unresectable pancreatic cancer is recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial evaluating BMS-986523 alone and in combination with anti-cancer agents in advanced solid malignancies, incl…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
A completed Travera Inc trial evaluating TraveraRTGx and a tumor-cell biomarker intended to guide rapid therapy decisions across multiple ca…